We talk to Dr Piet van der Graaf, Director of Discovery Biology and Head of Sexual Health, #Pfizer

We spoke to our Exploratory Clinical Drug Development 2012 speaker Dr Piet van der Graff from Pfizer regarding his thoughts on the current challenges within pre-clinical drug development. Here's what he had to say… Q. What challenges does your organisation face in forming highly predictive pre-clinical models to identify novel concepts relevant to human disease? · Rational and quantitative translation …

500 to be hired by Quintiles for new BPO hub in China

Just weeks after Quintiles announced plans to set up a new CRO based in Beijing came out another plans to open its fourth hub in China with plans to hire 500 workers for a new business process outsourcing operation that will cater to a broad range of biopharma clients with a multilingual staff based in Dalian. NC-based Quintiles plans to offer regional …

Lambda Therapeutic, a complete Clinical trial service provider

Lambda Therapeutic Research Ltd. is a full service Contract Research Organization having headquartered in Ahmedabad, India and also have facilities and operations in Mumbai (India), Toronto (Canada), Warsaw (Poland), London (UK) and USA. Lambda fully exploits potential of India to offer full spectrum of clinical trial services to pharmaceutical, biopharmaceutical and medical devices companies within timelines and stipulated cost while …

Andrew Tan on Dealing with Cancer and Obesity

Dr. Andrew Tan obtained a PhD in Cell and Molecular Biology at the National University of Singapore. This was followed by postdoctoral positions in National University of Singapore and Centre of for Integrative Genomics, Switzerland. In 2005, He joined the School of Biological Sciences at Nanyang Technological University. Current research centered on three processes which are of clinical relevance. Wound …

Curt Alexander Davey on Exploiting Chromatin Structure & Chemistry for Cancer Therapy

Curt Alexander Davey, Assistant Professor at Nanyang Technological University would be sharing on Exploiting Chromatin Structure & Chemistry for Cancer Therapy at BioPharma Asia Convention’s NTU-SBS Symposium at 2.40pm on 20 March 2012! Here’s a short profile of him: Staff Scientist/Post-Doctoral Fellow, 1998-2003, ETH-Zürich Post-Doctoral Fellow, 1996-1997, University of Miami Ph.D. in Biochemistry & Molecular Biology, 1991-1996, University of Miami School …

Richard J. Sugrue on Multidisciplinary approaches to identify essential virus and host cell interactions, for pleasure (and for profit?)

Richard J. Sugrue obtained a 1st class hon. degree in microbiology from University of London and a PhD in Biochemistry at the University of Kent working with Robert Freedman on protein folding. This was followed by research positions in the Virology Division at the Medical Research Councils (MRC) National Institute for Medical Research (NIMR) and the crystallography dept at Birkbeck …

Zbynek Bozdech on Functional genomics, proteomics and systems biology of human malaria

Zbynek Bozdech would be showcasing his excellence in research at BioPharma Asia Convention’s NTU SBS Symposium on 20 March 2012 at 3.30pm. Zbynek Bozdech has started his career at McGill University, Montreal, Canada where he completed his PhD in 1998. Subsequently, he became one of the pioneers of functional genomics of malaria parasites in during his postdoctoral studies at the University …

James P. Tam on Design Strategies for Peptide and Proteins as Druggable Biologics

Prof James P. Tam is the Director of the double-degree program in Biomedical Science and Chinese Medicine, the Founding Dean of the School of Biological Sciences and the Founding Director of Biological Research Centre at Nanyang Technological University, Singapore. He would be presenting ‘Design Strategies for Peptide and Proteins as Druggable Biologics’ at NTU’S  SBS Symposium at BioPharma Asia Convention …

Pär Nordlund on Structural biology and protein sciences to drive drug design

Pär Nordlund is structural biologist at School of Biological Sciences (SBS), Nanyang Technological University (NTU) and at Karolinska Institutet, Sweden. He would be presenting at NTU’s SBS Symposium at BioPharma Asia Convention on 20 March 2012 at 4.30pm. His research is focused on providing mechanistic insights into disease related proteins as well as the development of technologies to drive the …

We speak to Laurence Colin from #Novartis on challenges in early drug development

Whilst doing some research for the upcoming Exploratory Clinical Development World Europe conference we asked Laurence Colin, Disease Area Scientific Lead Statistician for Autoimmunity in Early Development, Novartis what challenges her organisation face in implementing new approaches for increasing productivity of drug development? Laurence's response was that there was not enough time and resources spent on clinical development plans and …